Azithromycin drugmakers to add adverse reaction AGEP in the package insert: CDSCO Panel Medical Dialogues Team21 Jan 2022 2:15 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drugs Standard Control Organization (CDSCO) has recommended that CDSCO may...
Drug-makers to add Fixed Drug Eruption (FDE) in the package insert of Doxycycline : CDSCO Panel Medical Dialogues Team19 Jan 2022 5:21 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drugs Standard Control Organization (CDSCO) has recommended that CDSCO may...
Drug makers to add Itraconazole linked Photosensitivity in package insert: CDSCO panel Medical Dialogues Team16 Jan 2022 11:30 AM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drugs Standard Control Organization (CDSCO) has recommended that CDSCO may...
Drug makers to include DPP4 inhibitors induced Arthralgia in package insert, says CDSCO panel Medical Dialogues Team15 Jan 2022 5:35 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drugs Standard Control Organization (CDSCO) has recommended that CDSCO may...
DCGI directs strict vigil on spurious Tocilizumab Injs distribution in India Medical Dialogues Team12 Jan 2022 5:13 PM ISTNew Delhi: Raising a safety alert, the Drugs Controller General of India, Central Drugs Standard Control Organisation (CDSCO) has directed all...
Novartis gets CDSCO panel nod to study Alpelisib for early (prophylactic) and sustained improvement of hyperglycemia Medical Dialogues Team9 Jan 2022 8:45 PM ISTNew Delhi: Pharmaceutical major Novartis has got a conditional nod from the Subject Expert Committee (SEC) of the Central Drugs Standard Control...
Novartis gets CDSCO panel nod to study Ligelizumab in treatment of chronic inducible urticaria Medical Dialogues Team7 Jan 2022 2:21 PM ISTNew Delhi: Pharma major Novartis has got a go ahead from the Subject Expert Committee (SEC) functional under the Central Drugs Standard Control...
IPC flags adverse reaction linked to popular COVID drug Remdesivir Medical Dialogues Team4 Jan 2022 6:55 PM ISTNew Delhi: The Indian Pharmacopoeia Commission (IPC), through its recently issued drug safety alert for the month of December, has revealed that...
Takeda Pharma gets CDSCO panel nod to market Vadolizumab for subcutaneous route Medical Dialogues Team2 Jan 2022 11:30 AM ISTNew Delhi: Takeda Pharmaceuticals has got the go ahead from the Subject Expert Committee (SEC) functional under the Central Drugs Standard Control...
13 pharma majors to launch anti-COVID drug Molnupiravir Medical Dialogues Team1 Jan 2022 7:36 PM ISTNew Delhi: Thirteen Indian pharmaceutical companies, including Torrent, Cipla, Sun Pharma, Dr Reddy's, Natco, Mylan, Hetero, Optimus will be...
NPPA fixes ceiling price of water for injection, Details Medical Dialogues Team31 Dec 2021 5:33 PM ISTNew Delhi: Through a recent notice, the National Pharmaceutical Pricing Authority (NPPA) has fixed the ceiling price of water for injection in 500 ml...
NPPA fixes retail price of 28 formulations, Details Medical Dialogues Team30 Dec 2021 7:01 PM ISTNew Delhi: Through a recent notice, the National Pharmaceutical Pricing Authority (NPPA), Ministry of Chemicals and Fertilizers, Government of India,...
